Tokyo Tape
Sign in
← AuBEX

Quarterly report · Q3

3583.TEDINET S100SSAY
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥5.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.0bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥400m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥507m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥418m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥639m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥519m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥417m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥561m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥297m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥469m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥365m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥297m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥365m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥9.4bnat 2023-12-31Cons.Assets
Total assets¥9.3bnat 2023-03-31Cons.Assets
Total assets¥9.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥3.3bnat 2023-12-31Cons.Liabilities
Total liabilities¥3.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥6.1bnat 2023-12-31Cons.Net assets
Net assets / equity¥5.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥5.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥2.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥106.792023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.592023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥169.172022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥131.722022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.342022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio64.6%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥861,000
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥103m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥2.8bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2023-04-01 → 2023-12-31¥535m
—segment totalrevenue2023-04-01 → 2023-12-31¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥3.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥861,000
—segment totalsegment profit2023-04-01 → 2023-12-31¥638m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥861,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥638m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥3m
jpcrp040300-q3r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥73m
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.9bn
jpcrp040300-q3r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥644m
—segment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
—segment totalsegment profit2022-04-01 → 2022-12-31¥717m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥4.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥3m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥717m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember3428000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3428000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember2907611000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember1060842000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember3968454000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3968454000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember644490000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember72687000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember717178000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember717178000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember2778187000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember1151232000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember3929420000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3929420000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember861000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember861000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember861000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember2778187000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember1152093000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember3930281000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3930281000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E00584-000TechnologicalProductsReportableSegmentsMember534938000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E00584-000MedicalProductsReportableSegmentsMember103086000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember638025000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember638025000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-02-09
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第139期第３四半期(自 2023年10月１日 至 2023年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)オーベクス株式会社
Company name in english cover pageFilingDateInstantAuBEX CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 栗 原 則 義
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00584
Fund codeFilingDateInstant－
Security codeFilingDateInstant35830
Filer name in japaneseFilingDateInstant
Original text (Japanese)オーベクス株式会社
Filer name in englishFilingDateInstantAuBEX CORPORATION
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass